Hemoglobin disorders
ChemistryAlso known as: Hemoglobin disorders DBS-ImpN/A
Detects abnormal hemoglobin variants associated with genetic blood disorders in newborns.
Normal Range
Consult your provider
N/A
Abnormal Levels
Consult your provider
Specimen Type
Blood
Why This Biomarker Matters
Newborn screening for hemoglobin disorders enables early diagnosis and treatment, preventing severe complications and improving long-term health outcomes.
Overview
This newborn screening test detects hemoglobin disorders using a small blood sample from a heel prick on a dried blood spot card. It identifies conditions like sickle cell disease and thalassemia, which cause abnormal hemoglobin production. Early detection through newborn screening allows immediate treatment and monitoring to prevent serious complications, including pain crises, organ damage, and stroke.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
46740-7PrimaryHemoglobin disorders newborn screen interpretation
Available Lab Tests
Order tests that measure this biomarker